Payment overview · 2025
General Payments
$59.05
3 reported records · 3 companies
Healthcare provider profile · identity verified
Michael B Daley, MD
Allopathic & Osteopathic Physicians|Internal Medicine · PINEHURST, NC · NPI 1407897846
Verified facts
What the public records show
CMS Open Payments records show Michael B Daley, MD received $59.05 in general payments during 2025 across 3 reported records.
GlaxoSmithKline, LLC. accounted for 41.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Trelegy Ellipta by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 340 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $24.56 | 41.6% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $20.42 | 34.6% | 1 | 2025 |
| InSightec,Inc | Unresolved — no canonical attribution shown | $14.07 | 23.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $59.05 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $24.56 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $24.56 | 1 | 2025 |
Source payment records
|
|||||
| VYNDAQEL Normalized: vyndaqel |
Drug | PFIZER INC. | $20.42 | 1 | 2025 |
Source payment records
|
|||||
| Exablate Normalized: exablate |
Device | InSightec,Inc | $14.07 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
20 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
340 | 62 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
24 | 24 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Furosemide | Furosemide | 715 | 218 |
| Amlodipine Besylate | Amlodipine Besylate | 579 | 171 |
| Atorvastatin Calcium | Atorvastatin Calcium | 523 | 156 |
| Losartan Potassium | Losartan Potassium | 466 | 143 |
| Levothyroxine Sodium | Levothyroxine Sodium | 463 | 129 |
| Spironolactone | Spironolactone | 443 | 119 |
| Omeprazole | Omeprazole | 420 | 133 |
| Metoprolol Succinate | Metoprolol Succinate | 388 | 106 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 345 | 95 |
| Gabapentin | Gabapentin | 344 | 101 |
| Eliquis | Apixaban | 340 | 62 |
| Lisinopril | Lisinopril | 332 | 99 |
| Atenolol | Atenolol | 287 | 76 |
| Tramadol Hcl | Tramadol Hcl | 278 | 81 |
| Pantoprazole Sodium | Pantoprazole Sodium | 255 | 69 |
| Metformin Hcl | Metformin Hcl | 224 | 62 |
| Potassium Chloride | Potassium Chloride | 207 | 57 |
| Simvastatin | Simvastatin | 202 | 57 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 194 | 47 |
| Jardiance | Empagliflozin | 184 | 35 |
| Prednisone | Prednisone | 184 | 108 |
| Allopurinol | Allopurinol | 180 | 47 |
| Pravastatin Sodium | Pravastatin Sodium | 179 | 49 |
| Zolpidem Tartrate | Zolpidem Tartrate | 167 | 32 |
| Carvedilol | Carvedilol | 164 | 45 |
| Sertraline Hcl | Sertraline Hcl | 156 | 53 |
| Tizanidine Hcl | Tizanidine Hcl | 156 | 36 |
| Tamsulosin Hcl | Tamsulosin Hcl | 150 | 45 |
| Glimepiride | Glimepiride | 149 | 44 |
| Montelukast Sodium | Montelukast Sodium | 148 | 38 |
| Xarelto | Rivaroxaban | 148 | 25 |
| Trazodone Hcl | Trazodone Hcl | 133 | 46 |
| Alprazolam | Alprazolam | 126 | 38 |
| Ozempic | Semaglutide | 125 | 23 |
| Lovastatin | Lovastatin | 117 | 33 |
| Fluoxetine Hcl | Fluoxetine Hcl | 115 | 32 |
| Indapamide | Indapamide | 112 | 29 |
| Hydrochlorothiazide | Hydrochlorothiazide | 111 | 36 |
| Fluticasone Propionate | Fluticasone Propionate | 106 | 45 |
| Duloxetine Hcl | Duloxetine Hcl | 103 | 34 |
| Pregabalin | Pregabalin | 103 | 23 |
| Lorazepam | Lorazepam | 102 | 19 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 101 | 24 |
| Azithromycin | Azithromycin | 100 | 83 |
| Trulicity | Dulaglutide | 98 | 17 |
| Clonazepam | Clonazepam | 96 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 96 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 92 | 20 |
| Irbesartan | Irbesartan | 91 | 21 |
| Meloxicam | Meloxicam | 86 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 83 | 37 |
| Fenofibrate | Fenofibrate | 82 | 16 |
| Metoprolol Tartrate | Metoprolol Tartrate | 82 | 26 |
| Famotidine | Famotidine | 80 | 23 |
| Quetiapine Fumarate | Quetiapine Fumarate | 79 | 18 |
| Amoxicillin | Amoxicillin | 75 | 45 |
| Torsemide | Torsemide | 75 | 22 |
| Paroxetine Hcl | Paroxetine Hcl | 74 | 22 |
| Ezetimibe | Ezetimibe | 73 | 28 |
| Memantine Hcl | Memantine Hcl | 72 | 16 |
| Breo Ellipta | Fluticasone/Vilanterol | 70 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 70 | 15 |
| Telmisartan | Telmisartan | 70 | 19 |
| Warfarin Sodium | Warfarin Sodium | 68 | 20 |
| Donepezil Hcl | Donepezil Hcl | 65 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 64 | 15 |
| Ondansetron Odt | Ondansetron | 64 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 62 | 20 |
| Alendronate Sodium | Alendronate Sodium | 61 | 20 |
| Valsartan | Valsartan | 61 | 23 |
| Escitalopram Oxalate | Escitalopram Oxalate | 60 | 22 |
| Ibandronate Sodium | Ibandronate Sodium | 59 | 24 |
| Cephalexin | Cephalexin | 58 | 37 |
| Nitroglycerin | Nitroglycerin | 57 | 34 |
| Synthroid | Levothyroxine Sodium | 57 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 56 | 13 |
| Fluconazole | Fluconazole | 55 | 26 |
| Mirtazapine | Mirtazapine | 55 | 18 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 53 | 33 |
| Mounjaro | Tirzepatide | 52 | 11 |
| Verapamil Er | Verapamil Hcl | 52 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 51 | 15 |
| Pioglitazone Hcl | Pioglitazone Hcl | 51 | 16 |
| Candesartan Cilexetil | Candesartan Cilexetil | 50 | suppressed |
| Diazepam | Diazepam | 50 | 15 |
| Celecoxib | Celecoxib | 49 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 49 | 13 |
| Temazepam | Temazepam | 48 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 47 | 12 |
| Finasteride | Finasteride | 47 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 47 | 11 |
| Bumetanide | Bumetanide | 46 | 16 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 45 | 11 |
| Eplerenone | Eplerenone | 43 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 43 | 14 |
| Promethazine Hcl | Promethazine Hcl | 41 | suppressed |
| Estradiol | Estradiol | 40 | 15 |
| Januvia | Sitagliptin Phosphate | 39 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 37 | 12 |
| Meclizine Hcl | Meclizine Hcl | 37 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 37 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 36 | 19 |
| Metolazone | Metolazone | 36 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 35 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 34 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 34 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 32 | 11 |
| Enalapril Maleate | Enalapril Maleate | 31 | suppressed |
| Linzess | Linaclotide | 31 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 29 | 17 |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Colchicine | Colchicine | 28 | 16 |
| Azelastine Hcl | Azelastine Hcl | 27 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 27 | 23 |
| Dicyclomine Hcl | Dicyclomine Hcl | 27 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 27 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 22 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | 12 |
| Metformin Hcl Er | Metformin Hcl | 25 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 25 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 24 | suppressed |
| Methotrexate | Methotrexate Sodium | 24 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 24 | 24 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 17 |
| Benazepril Hcl | Benazepril Hcl | 22 | suppressed |
| Digoxin | Digoxin | 22 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 22 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 21 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 21 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 21 | suppressed |
| Acyclovir | Acyclovir | 20 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 20 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 20 | 16 |
| Raloxifene Hcl | Raloxifene Hcl | 20 | suppressed |
| Ramipril | Ramipril | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 19 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Nifedipine Er | Nifedipine | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | 16 |
| Tresiba Flextouch U-100 | Insulin Degludec | 18 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Movantik | Naloxegol Oxalate | 17 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 17 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Sotalol | Sotalol Hcl | 16 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Cilostazol | Cilostazol | 14 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 14 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 14 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 14 | suppressed |
| Nystatin | Nystatin | 14 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 13 | suppressed |
| Entresto | Sacubitril/Valsartan | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Rybelsus | Semaglutide | 13 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Aripiprazole | Aripiprazole | 12 | suppressed |
| Budesonide Dr | Budesonide | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Klor-Con M10 | Potassium Chloride | 12 | suppressed |
| Np Thyroid | Thyroid,pork | 12 | suppressed |
| Repatha Syringe | Evolocumab | 12 | suppressed |
| Trimethoprim | Trimethoprim | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | 11 |
| Amantadine | Amantadine Hcl | 11 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $59.05 · 3 records | GlaxoSmithKline, LLC. | AREXVY, Exablate, SHINGRIX, VYNDAQEL | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error